Literature DB >> 16054137

Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys.

Ilana Sabanay1, Baohe Tian, B'Ann T Gabelt, Benjamin Geiger, Paul L Kaufman.   

Abstract

To determine the mechanism of latrunculin B (LAT-B)-induced decrease in outflow resistance and the effect of LAT-B on the cornea, structural changes of the trabecular meshwork (TM) and the corneal endothelium following LAT-B were studied in the live monkey eye. LAT-B (0.5 microM) and vehicle were administered by anterior chamber exchange and infusion with cationized and non-cationized gold solution in opposite eyes. The eyes were fixed by infusing Ito's solution and enucleated. Anterior segments were quadrisected and embedded in Epon-Embed 812. Morphology of the TM and the corneal endothelium was studied by light and electron microscopy. LAT-B-induced morphological changes in the TM included: (1) loss of microfilament integrity in cells, especially in TM cells on the collagen beams; (2) development of numerous cytoplasmic projections of the sub-canalicular cells (SUB); (3) reorganization of intermediate filaments in Schlemm's canal inner wall (IW) cells; (4) massive 'ballooning' of the juxtacanalicular (JXT) region, leading to a substantial expansion of the space between the IW of Schlemm's canal and the trabecular collagen beams; and (5) retention of extracellular matrix (ECM), trapped between the SUB cell layer and IW cells. No detrimental effects on tight junctions, giant vacuoles, and cell-cell and cell-ECM adhesions were observed. Endocytosis of gold particles was not affected. Morphology of the corneal endothelium of the LAT-B-treated eye was unchanged. In conclusion, TM changes in the LAT-B-treated eye suggest that the expansion of the JXT space may account for the decrease in outflow resistance induced by latrunculins. The outflow-effective concentration of LAT-B administered intracamerally does not significantly affect the corneal endothelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054137     DOI: 10.1016/j.exer.2005.06.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  31 in total

Review 1.  Deconstructing aqueous humor outflow - The last 50 years.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2020-06-23       Impact factor: 3.467

2.  Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.

Authors:  Joshua A Wood; Clayton T McKee; Sara M Thomasy; Marion E Fischer; Nihar M Shah; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-02       Impact factor: 4.799

3.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

Review 4.  Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2007-10-26       Impact factor: 3.467

5.  Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes.

Authors:  Chen-Yuan Charlie Yang; Ye Liu; Zhaozeng Lu; Ruiyi Ren; Haiyan Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

Review 6.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

7.  Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway.

Authors:  Toshihiro Inoue; Padmanabhan P Pattabiraman; David L Epstein; P Vasantha Rao
Journal:  Exp Eye Res       Date:  2009-12-02       Impact factor: 3.467

8.  The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes.

Authors:  Zhaozeng Lu; Darryl R Overby; Patrick A Scott; Thomas F Freddo; Haiyan Gong
Journal:  Exp Eye Res       Date:  2007-11-05       Impact factor: 3.467

9.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

10.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.